[ad_1]
New York, April 13, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Acute Coronary Syndrome Therapeutic Market Research Report by Type, Drug, Treatment, Diagnosis, End User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” – https://www.reportlinker.com/p06262423/?utm_source=GNW
The Global Acute Coronary Syndrome Therapeutic Market size was estimated at USD 8,092.56 million in 2021 and expected to reach USD 8,657.44 million in 2022, and is projected to grow at a CAGR 7.15% to reach USD 12,252.27 million by 2027.
Market Statistics:
The report provides market sizing and forecast across five major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Acute Coronary Syndrome Therapeutic to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Non-ST-elevation Myocardial Infarction, ST-elevation Myocardial Infarction, and Vial Unstable Angina.
Based on Drug, the market was studied across Antihypertensive, Antithrombotic, and Statins.
Based on Treatment, the market was studied across Drug Treatment, Post Discharge Treatment, Prehospital Care, and Reperfusion Therapy. The Drug Treatment is further studied across Antianginal Drug, Anticoagulant, and Antiplatelet Drug.
Based on Diagnosis, the market was studied across Blood Tests, Computerized Tomography Angiogram, Coronary Angiogram, Echocardiogram, and Imaging.
Based on End User, the market was studied across Academic Institutes, Diagnostic Centers, and Hospital & Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an…
Full story available on Benzinga.com
[ad_2]
Source link
